Inhibitory Antibodies
-
F2018 Anti-INHBB/Activin B Antibody (Oxford Brookes U. patent anti-Activin Beta-B)Summary: Anti-INHBB/Activin B Antibody (Oxford Brookes U. patent anti-Activin Beta-B) -
F2017 Anti-IL-6/IFNb2 Antibody (Merck patent anti-IL-6)Summary: Anti-IL-6/IFNb2 Antibody (Merck patent anti-IL-6) -
F2016 Anti-IL-6/IFNb2 Antibody (Medarex patent anti-IL-6)Summary: Anti-IL-6/IFNb2 Antibody (Medarex patent anti-IL-6) -
F2015 Anti-IL-6/IFNb2 Antibody (CSTRI patent anti-IL-6)Summary: Anti-IL-6/IFNb2 Antibody (CSTRI patent anti-IL-6) -
F2014 Anti-IL-3Ra/CD123 Antibody (Talacotuzumab-MMAE)Summary: Anti-IL-3Ra/CD123 Antibody (Talacotuzumab-MMAE) -
F2013 Anti-IL-2Rb/CD122 Antibody (Singapore ASTR patent anti-IL-2R beta / IL-2R gamma )Summary: Anti-IL-2Rb/CD122 Antibody (Singapore ASTR patent anti-IL-2R beta / IL-2R gamma ) -
F2012 Anti-IL-21 Antibody (Lilly patent anti-IL-21)Summary: Anti-IL-21 Antibody (Lilly patent anti-IL-21) -
F2011 Anti-IL-20Ra Antibody (Cheng Kung U. patent anti-IL-20R1)Summary: Anti-IL-20Ra Antibody (Cheng Kung U. patent anti-IL-20R1) -
F2010 Anti-IL-20 Antibody (Cheng Kung U. patent anti-IL-20)Summary: Anti-IL-20 Antibody (Cheng Kung U. patent anti-IL-20) -
F2009 Anti-IL-13Ra2/CD213a2 Antibody (Wake Forest U. patent anti-IL-13RA2)Summary: Anti-IL-13Ra2/CD213a2 Antibody (Wake Forest U. patent anti-IL-13RA2)